JS
Insider
Jeffrey N Simmons
PRESIDENT, CEO AND DIRECTORJeffrey N Simmons (PRESIDENT, CEO AND DIRECTOR) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Elanco Animal Health Incorporated (ELAN). Across 1 priced purchase filing, the average 21-session return was +11.9% from execution and +13.7% from disclosure (delay-adjusted; derived). The largest single filing was $478K of ELAN (22,000 sh × $21.75, as filed), executed Dec 11 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+11.9%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+13.7%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$478K
shares × price, as filed
Last traded
Dec 11 2025
Filed Dec 15 2025
Median ADV $140.0M across their filed names
Open performance→Volume by month
Buys $478K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ELANRecent filings
ELANPURCHASE
Elanco Animal Health Incorporated
View filing →
$478K22,000 sh × $21.75
Exec Dec 11 2025
Filed Dec 15 2025 · 4:41 PM ET